IRF4 and obesity disorder: In contrast, there was no difference in blood glucose levels in HFD‐fed, male AdipoIRF4fl/fl mice treated with MDP (Figure 2b), supporting a role for adipocyte IRF4 in mediating the glucose‐lowering effects of MDP during obesity in male mice.